Navigation Links
New Option for Erasing Wrinkles

Dysport® cosmetic injection receives U.S. FDA Approval

(Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors' offices in July: the U.S. FDA has approved the cosmetic injectable Dysport®. Dysport®, approved in the European Union, Brazil, Argentina and more than 26 countries worldwide is a form of botulinum type A, similar to the protein found in Botox® Cosmetic, approved for fighting wrinkles in the U.S. since 2004. Dysport® and Botox® are both cosmetic injections that temporarily relax the muscles in the face that create expressions, such as frown lines between the brows, that over time result in visible facial lines and deeper creases. "Although their action is similar, Dysport® and Botox® Cosmetic are two different drugs," said oculoplastic surgeon Dr. Brian Biesman, Coalition leader and Assistant Clinical Professor at Vanderbilt University Medical Center in Nashville, TN. "Both temporarily modify the action of facial muscles, smoothing out undesirable lines between the brows, across the forehead or crow's feet to restore a more youthful, less stressed appearance. But they are not interchangeable, they have distinct dosing differences."

"Cosmetic injections of any kind require examination, the informed consent process and prescription, including the proper dose, by a qualified board-certified plastic surgeon, facial plastic surgeon, oculoplastic surgeon or dermatologist, to achieve both a visually pleasing and a safe outcome. The doctor you choose should also either provide the injection or directly supervise the registered nurse (R.N) or physician's assistant (P.A.) who will inject you," said plastic surgeon and Coalition leader Mark Codner, MD, of Atlanta, GA. "In my practice, I inject all my patients personally. You have the right to request that your doctor perform the injection if you wish."

"Whether Dysport® or Botox® Cosmetic is right for you is a decision between you and your doctor; in every instance communication is key. If you have been injected with one or the other in the past, let your doctor know," recommended Coalition leader Mary Lynn Moran, MD, a San Francisco, CA, area facial plastic surgeon. "These are immensely safe treatments, more than 21 million people have been injected with genuine Dysport® or Botox® Cosmetic in the U.S. by qualified doctors in the past decade* and rarely have there been complications. The most serious complications reported from these injections are a temporary eyelid droop; its rare, data shows it occurs in less than 2% of patients, and well-trained doctors can usually avoid this outcome."

"Cosmetic injections are a category of cosmetic medicine really only a decade old," said Coalition leader Dr. Richard D'Amico, a plastic surgeon from Englewood. NJ. "There is a lot for consumers to learn, and unfortunately, with the valid information there is also hype and hearsay that includes physicians who are not trained in medical aesthetics, and who lack lack the training and credentials necessary to ensure safety and excellent results. The goal of the Coalition has been to provide consumers a complete, authoritative and unbiased resource for this information," said Dr. D'Amico. "No consumer should have an injection without visiting, first."

The Coalition, who this week launches a new, consumer friendly site with video, FAQs and more, offers consumers extensive, easy to use resources including a cosmetic injection planner with all the questions you must ask your provider at In addition, an up-to-date listing of the status of investigational and approved cosmetic injection drugs and devices is available on the site, as well as pictures that will help consumers identify a genuine brand. Consumers are urged to ask these simple questions before considering any cosmetic injectable procedure:

  • Doctor: Is the injectable recommended by a qualified doctor who regularly treats similar conditions, in an appropriately licensed and equipped medical facility? Has the doctor examined the prospective patient before recommending treatment?
  • Brand: Is the injectable recommended approved by the U.S. FDA,, and by equivalent agencies in the country of origin, for cosmetic indications and is it appropriately labeled and packaged to reflect its authenticity and approval?
  • Safety: Is the setting a proper medically-equipped office, with safety and sterilization procedures? Has the physician evaluated conditions, recommended treatment, offered alternatives and clearly defined the potential outcomes including any complications?

*Compiled from the 1997-2008 Cosmetic Surgery National Data Bank Statistics of multi-specialty data;

About Us
The Physicians Coalition for Injectable Safety is an alliance of specialty physician organizations including the American Society for Aesthetic Plastic Surgery, American Academy of Facial Plastic and Reconstructive Surgery, the American Society of Ophthalmic Plastic and Reconstructive Surgery, the American Society of Plastic Surgeons, the International Society for Aesthetic Plastic Surgery, the International Federation of Facial Plastic and Reconstructive Surgeons, and the Canadian Society for Aesthetic Plastic Surgery. The mission of the Coalition is to provide the public with unbiased and necessary information on injectable cosmetic treatments, appropriate injectors and where to safely access cosmetic medical procedures. Our goal is to promote treatment supervised by properly qualified and trained, board-certified doctors and to promote only the use of U.S. FDA-approved, appropriately administered product. More information can be found at

Adeena Babbitt


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Conceptual Options, a Center for Surrogacy & Egg Donation, Announces Third Party Assurance Program
2. Americas Future Now Straw Poll: Progressives See Health Care Reform With Public Option As Top Priority
3. Weight-Loss Surgery Options Compared in Super-Obese
4. Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs, Accelerates I.T. Adoption by Providers and Health Plans
5. Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records
6. ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML
7. Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options
8. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
9. CBay Announces the MTSO Partnership Program to Drive Digital Health Record Adoption
10. Caldwell Consumer Health Becomes Revive Personal Products, Inc., with OPTIONS(TM) Line of Womens Sexual Health Products & Oral Health Brands; See Us at NACDS Booth 533 (The Emerson Group)
11. Health Affairs Report On Mass. Mandatory Insurance Law Confirms: Strong Public Option Must Be Included in National Health Reform
Post Your Comments:
Related Image:
New Option for Erasing Wrinkles
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: